The Beauty Health Company (NASDAQ:SKIN) Shares Sold by Susquehanna Portfolio Strategies LLC

Susquehanna Portfolio Strategies LLC reduced its holdings in shares of The Beauty Health Company (NASDAQ:SKIN - Free Report) by 66.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 109,508 shares of the company's stock after selling 215,867 shares during the quarter. Beauty Health makes up 0.6% of Susquehanna Portfolio Strategies LLC's investment portfolio, making the stock its 11th largest position. Susquehanna Portfolio Strategies LLC owned approximately 0.09% of Beauty Health worth $174,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. ProShare Advisors LLC raised its holdings in shares of Beauty Health by 49.0% in the fourth quarter. ProShare Advisors LLC now owns 20,959 shares of the company's stock worth $33,000 after acquiring an additional 6,896 shares during the last quarter. Millennium Management LLC increased its position in Beauty Health by 30.6% during the 4th quarter. Millennium Management LLC now owns 3,118,970 shares of the company's stock worth $4,959,000 after purchasing an additional 730,647 shares in the last quarter. Bridgeway Capital Management LLC increased its position in Beauty Health by 13.6% during the 4th quarter. Bridgeway Capital Management LLC now owns 1,211,600 shares of the company's stock worth $1,926,000 after purchasing an additional 145,000 shares in the last quarter. BNP Paribas Financial Markets acquired a new position in Beauty Health in the 4th quarter valued at about $129,000. Finally, Northern Trust Corp lifted its holdings in Beauty Health by 6.8% in the 4th quarter. Northern Trust Corp now owns 663,752 shares of the company's stock valued at $1,055,000 after purchasing an additional 42,078 shares in the last quarter. Institutional investors and hedge funds own 93.26% of the company's stock.

Beauty Health Trading Down 6.6%

Shares of Beauty Health stock traded down $0.12 during trading hours on Friday, reaching $1.62. 145,420 shares of the company's stock were exchanged, compared to its average volume of 1,048,991. The Beauty Health Company has a 52-week low of $0.78 and a 52-week high of $2.70. The company has a fifty day moving average of $1.23 and a 200-day moving average of $1.45. The company has a current ratio of 6.56, a quick ratio of 5.57 and a debt-to-equity ratio of 9.23. The firm has a market capitalization of $202.27 million, a price-to-earnings ratio of -3.85 and a beta of 0.88.

Beauty Health (NASDAQ:SKIN - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.05. Beauty Health had a negative return on equity of 44.83% and a negative net margin of 8.11%. The firm had revenue of $69.60 million during the quarter, compared to analyst estimates of $63.88 million. Sell-side analysts forecast that The Beauty Health Company will post -0.25 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group decreased their price target on shares of Beauty Health from $1.50 to $1.25 and set a "hold" rating on the stock in a research note on Monday, May 5th.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.